URGN NASDAQ
UroGen Pharma Ltd.
1W: +0.7%
1M: +14.7%
3M: +41.8%
YTD: +31.6%
1Y: +296.3%
3Y: +154.3%
5Y: +96.6%
$28.89
-0.99 (-3.31%)
Weekly Expected Move ±11.5%
$22
$25
$29
$32
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$116M
Revenue
+26.6% YoY
$-83M
Net Income
+39.8% YoY
$-166M
Free Cash Flow
-54.6% YoY
91.9%
Gross Margin
-39.8%
Op. Margin
-46.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE145.8%
ROA-34.3%
ROIC54.0%
Valuation
P/E-10.9
P/B-11.7
EV/EBITDA-13.5
Leverage
Debt/Equity-1.22
Current Ratio4.01
Interest Cov.-2.3x
Quality Scores
Piotroski F3/9
Altman Z-4.66
Beneish M0.51